Radboud university medical center study sets new milestone with 90% diagnostic accuracy of lung nodules suspected of cancer using Philips technology for bronchoscopic procedures
06 oct. 2021 08h00 HE
|
Royal Philips
October 4, 2021 Radboud university medical center study sets new milestone with 90% diagnostic accuracy of lung nodules suspected of cancer using Philips technology for bronchoscopic procedures ...
Clinical experts establish first-ever global consensus for the appropriate use of intravascular ultrasound (IVUS) in peripheral vascular disease interventions
05 oct. 2021 11h00 HE
|
Royal Philips
October 5, 2021 First global analysis of IVUS by interventional cardiology, interventional radiology, and vascular surgery experts in peripheral vascular disease (PVD) interventionsConsensus...
Lankenau Heart Institute, part of Main Line Health, first in North America to sign long-term strategic partnership with Philips utilizing integrated cardiovascular solutions
30 sept. 2021 09h00 HE
|
Royal Philips
September 30, 2021 Unique five-year agreement will help Philadelphia-based health leader integrate and standardize innovative cardiovascular care, helping to deliver on the quadruple aim Amsterdam,...
Philips Genomics Workspace enables integration of the largest-scale FDA-cleared cancer genetic test at NYU Langone Health
03 août 2021 09h00 HE
|
Royal Philips
August 3, 2021 Philips and NYU Langone Health Department of Pathology, a premier NCI (National Cancer Institute) designated comprehensive cancer center, collaborate for genomic processing,...
Philips receives FDA Breakthrough Device Designation for laser-assisted IVC filter removal device
21 juil. 2021 09h00 HE
|
Royal Philips
July 21, 2021 FDA Breakthrough Device Designation is granted to novel medical devices that have the potential to provide more effective treatmentIt is estimated that in the United States more than...
Philips accelerates stroke diagnosis and treatment with expanded integrated solutions and strategic partnership
07 juil. 2021 04h05 HE
|
Royal Philips
July 7, 2021 Expanded capabilities of Philips Image Guided Therapy System – Azurion – and new collaboration with NICO.LAB add to the latest advances in Philips’ commitment to reduce time to...
Philips announces first patient enrolled in the WE-TRUST global multicenter stroke study to assess the impact of the Direct to Angio Suite workflow in improving patient outcomes
07 juil. 2021 04h00 HE
|
Royal Philips
July 7, 2021 First patient enrolled in global multi-center randomized controlled trial with 564 patients at 15 sites comparing the impact of the Direct to Angio Suite workflow (diagnosis and...
Philips announces first patient treated with its new real-time 3D intracardiac echocardiography catheter – VeriSight Pro
01 juil. 2021 09h00 HE
|
Royal Philips
July 01, 2021 FDA 510k-cleared real-time 3D intracardiac echocardiography (ICE) catheter has potential to improve standard of care for structural heart disease and electrophysiology procedures...
Philips and the Spanish National Center for Cardiovascular Research (CNIC) collaborate on a new ultra-fast cardiac MRI protocol for research purposes with the aim of benefitting clinical practice in the future
30 juin 2021 08h00 HE
|
Royal Philips
June 30, 2021 Ultra-fast, less than one-minute scan time, cardiac MRI enables accurate assessment of heart anatomy and function, improves patient comfort, increases access to care, and reduces...
Philips announces first patient enrollment in DEFINE GPS global multicenter study to assess superiority of PCI procedures guided by co-registered iFR and interventional angiography
22 juin 2021 09h00 HE
|
Royal Philips
June 22, 2021 First patient enrolled in global randomized controlled trial with up to 3,200 participants at 100 sites comparing patient outcomes after percutaneous coronary intervention (PCI)...